Journal article
ECHS1 mutations in Leigh disease: A new inborn error of metabolism affecting valine metabolism
H Peters, N Buck, R Wanders, J Ruiter, H Waterham, J Koster, J Yaplito-Lee, S Ferdinandusse, J Pitt
Brain | Published : 2014
DOI: 10.1093/brain/awu216
Abstract
Two siblings with fatal Leigh disease had increased excretion of S-(2-carboxypropyl)cysteine and several other metabolites that are features of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency, a rare defect in the valine catabolic pathway associated with Leigh-like disease. However, this diagnosis was excluded by HIBCH sequencing and normal enzyme activity. In contrast to HIBCH deficiency, the excretion of 3-hydroxyisobutyryl-carnitine was normal in the children, suggesting deficiency of short-chain enoyl-CoA hydratase (ECHS1 gene). This mitochondrial enzyme is active in several metabolic pathways involving fatty acids and amino acids, including valine, and is immediately upstream of HI..
View full abstractGrants
Funding Acknowledgements
Sections of this work were supported by the Victorian Government's Operational Infrastructure Support Program.